{"schema_version":"secwatch.filing_event.v1","accession":"0001609550-24-000034","form_type":"8-K","ticker":"INSP","cik":"0001609550","company_name":"Inspire Medical Systems, Inc.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.761512+00:00","generated_at":"2026-05-31T15:43:50.578062+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Inspire Medical pre-announces Q2 revenue $195.9M (+30% YoY), raises 2024 guidance to $788-798M","bullets":["Q2 revenue $195.9M, up 30% YoY; US revenue $187.8M (+30%), OUS $8.1M (+27%).","Full-year 2024 revenue guidance raised to $788-798M, up $13M from prior $775-785M range.","Management cites strong execution and sequential US revenue growth acceleration.","Complete Q2 results and earnings call scheduled for August 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001609550-24-000034","json":"https://secwatch.observer/filing/0001609550-24-000034.json","markdown":"https://secwatch.observer/filing/0001609550-24-000034.md","text":"https://secwatch.observer/filing/0001609550-24-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/0001609550-24-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/insp-20240729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:43:50.578062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}